The family history: The first genetic test, and still useful after all those years?

Genetics in Medicine

Volumn 14, Issue 1, 2012, Pages 3-9

  Pyeritz, Reed E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

clinical utility; family history; genealogy; genetic testing

Indexed keywords

CLINICAL PRACTICE; DIAGNOSTIC VALUE; FAMILY HISTORY; GENEALOGY; GENETIC DISORDER; GENETIC SCREENING; HUMAN; PERSONALIZED MEDICINE; REVIEW; VALIDITY;

EID: 85027940881     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.0b013e3182310bcf     Document Type: Review

References (73)

1. The Genuine Work of Hippocrates (translated from the Greek by Francis Adams). RE Krieger: Huntington, NY, 1972.
2. Margotta R. The Story of Medicine. Golden Press: New York, 1968:68.
3. Talmud B. Tractate Yebamoth 64b. http://www.come-and-hear.com/yebamoth/ yebamoth-64.html. Accessed 9 April 2011.
4. Otto JC. An account of an hemorrhagic disposition existing in certain families. Clin Orthop Relat Res 1996;328:4-6.
5. Hay J. Account of a remarkable haemorrhagic disposition, existing in many individuals of the same family. N Engl J Med 1813;2:221-225.
6. Pearson K. Treasury of Human Inheritance, vol. 1. Dulau: London, 1912.
7. Bell J, Haldane JBS. The linkage between the genes for colour-blindness and haemophilia in man. Proc R Soc Lond B 1937;123:119-150.
8. Garrod AE. About alkaptonuria. Lancet 1901;2:1484-1486.
9. Bateson W, Saunders ER. Experimental studies in the physiology of heredity. Rep Evol Comm Royal Soc Lond 1902;1:133-134.
10. Garrod A. The incidence of alkaptonuria: a study in chemical individuality. Lancet 1902;2:1616-1630.
11. Garrod AE. Inborn Errors of Metabolism. Oxford University Press: Oxford, UK, 1909.
12. Farabee WC. Hereditary and Sexual Influence in Meristic Variation: A Study of Digital Malformations in Man, PhD Thesis. Harvard University (pub.): Cambridge, MA, 1903.
13. Farabee WC. Inheritance of digital malformation in man. Pap Peabody Mus Am Archeol Ethnol 1905;3:69-77.
14. Horner JF. Die Erblichkeit des Daltonismus. In: Amtlicher Berichtüber die Verwaltung des Medizinalwesens des Kantons Zürich vom Jahr 1876. Druck der Genossenschaftsbuchdruckerei: Zurich, 1876;208-211.
15. Wilson EB. The sex chromosomes. Arch Mikrosk Anat Enwicklungsmech 1911;77:249-271.
16. Bean RB, compiler. Sir William Osler: Aphorisms From his Bedside Teachings and Writings. Charles C. Thomas: Springfield, MO, 1968.
17. Pearson K. A first study of the statistics of pulmonary tuberculosis. JAMA 1908;50:1042 (reprinted in JAMA 2008;299:1372).
18. Lynch CJ, Pierce-Chase CH, Dubos R. A genetic study of susceptibility to experimental tuberculosis in mice infected with mammalian tubercle bacilli. J Exp Med 1965;121:1051-1070.
19. Childs B. Genetic Medicine: A Logic of Disease. Johns Hopkins University Press: Baltimore, MD, 1999.
20. Degowin EL, Degowin RL. Bedside Diagnostic Examination, 2nd edn. Macmillan: New York, 1969.
21. US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd edn. Williams & Wilkins: Baltimore, MD, 1996.
22. Pyeritz RE. Approach to the patient with a hereditary disorder. In: Stobo J, Hellmann D, Ladenson P, Petty B, Traill TA (eds). Principles and Practice of Medicine, 23rd edn. Appleton & Lange: New York, 1996;683-689.
23. Rich EC, Burke W, Heaton CJ, et al. Reconsidering the family history in primary care. J Gen Intern Med 2004;19:273-280. (Pubitemid 38388939)
24. Williams JL, Collingridge DS, Williams MS. Primary care physicians' experience with family history: an exploratory qualitative study. Genet Med 2011;13:21-25.
25. Doukas DJ, Berg JW. The family covenant and genetic testing. Am J Bioeth 2001;1:2-10.
26. Bennett RL. Pedigree parables. Clin Genet 2000;58:241-249.
27. McGuire AL, Fisher R, Cusenza P, et al. Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider. Genet Med 2008;10:495-499.
28. http://www.hhs.gov/ocr/privacy/familyhealthhistoryfaqs.pdf. Accessed 4 July 2011.
29. Klitzman R. Exclusion of genetic information from the medical record: ethical and medical dilemmas. JAMA 2010;304:1120-1121.
30. Gollust SE, Gordon ES, Zayac C, et al. Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research Participants. Public Health Genomics 2011; e-pub ahead of print 3 June 2011.
31. Berg AO, Baird MA, Botkin JR, et al. National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. Ann Intern Med 2009;151:872-877.
32. Medalie JH, Zyzanski SJ, Goodwin MA, Stange KC. Two physician styles of focusing on the family. J Fam Pract 2000;49:209-215.
33. Volk LA, Staroselsky M, Newmark LP, et al. Do physicians take action on high risk family history information provided by patients outside of a clinic visit? Stud Health Tech Inform 2007;129(Pt 1):13-17.
34. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med 2000;2:180-185. (Pubitemid 32010820)
35. Frezzo TM, Rubinstein WS, Dunham D, Ormond KE. The genetic family history as a risk assessment tool in internal medicine. Genet Med 2003;5:84-91. (Pubitemid 36992617)
36. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002;20:528-537. (Pubitemid 34072538)
37. Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010;16:407-416.
38. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339-2350.
39. Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med 2009;150:541-550.
40. Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006;8:102-108.
41. Zlot AI, Bland MP, Silvey K, Epstein B, Mielke B, Leman RF. Influence of family history of diabetes on health care provider practice and patient behavior among nondiabetic Oregonians. Prev Chronic Dis 2009;6:A27.
42. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008;359:2208-2219.
43. Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol 2001;87:129-135. (Pubitemid 32057219)
44. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med 2006;8:491-501.
45. Nasir K, Budoff MJ, Wong ND, et al. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;116:619-626. (Pubitemid 47356346)
46. Scheuner MT, Setodji CM, Pankow JS, Blumenthal RS, Keeler E. Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Genet Med 2008;10:879-887.
47. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 2006;114:1462-1467. (Pubitemid 44527000)
48. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health. Genet Med 2010;12:839-843.
49. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009;150: 65-72.
50. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 2010;303:648-656.
51. Metcalfe K, Lubinski J, Lynch HT, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst 2010;102:1874-1878.
52. Centers for Disease Control and Prevention. Awareness of family history as a risk factor for disease-United States. MMWR Morb Mortal Wkly Rep 2004;53:1044-1047.
53. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ. Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 2009;6:A33.
54. Acheson LS, Wang C, Zyzanski SJ, et al. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the Family Healthware™ impact trial. Gent Med 2010;12:212-218.
55. Rubinstein WS, O'Neill SM, Rothrock N, et al. Components of family history associated with women's disease perceptions for cancer: report from the Family Healthware™ impact trial. Gent Med 2011;13:52-62.
56. Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 2001;33(2 Pt 1):128-136. (Pubitemid 32744641)
57. Ziogas A, Horick NK, Kinney AY, et al. Clinically relevant changes in family history of cancer over time. JAMA 2011;306:172-178.
58. Taylor DP, Stoddard GJ, Burt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med 2011;13:385-391.
59. Acheson LS. Recording, interpreting, and updating the family history of cancer: implications for cancer prevention. JAMA 2011;306:208-210.
60. Ruffin MT IV, Nease DE Jr, Sen A, et al. Effect of preventive messages tailored to family history on health behaviors: The Family Healthware Impact Trial. Ann Fam Med 2011;9:3-11.
61. Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N Engl J Med 2004;351:2333-2336. (Pubitemid 39552752)
62. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-197.
63. Su Y, Howard HC, Borry P. Users' motivations to purchase direct-toconsumer genome-wide testing: an exploratory study of personal stories. J Community Genet, in press.
64. Qureshi N, Wilson B, Santaguida P. Collection and Use of Cancer Family History in Primary Care. Evidence Report/Technology Assessment No. 159. Agency for Healthcare Research and Quality: Rockville, MD, 2007.
65. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011;13:597-605.
66. Fisher TJ, Kirk J, Hopper JL, Godding R, Burgemeister FC. A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. Breast 2003;12:120-127. (Pubitemid 36546436)
67. Qureshi N, Bethea J, Modell B, et al. Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 2005;22:663-669. (Pubitemid 43091136)
68. Acheson LS, Zyzanski SJ, Stange KC, Deptowicz A, Wiesner GL. Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. J Clin Oncol 2006;24:5395-5402. (Pubitemid 46623171)
69. Facio FM, Feero WG, Linn A, Oden N, Manickam K, Biesecker LG. Validation of My Family Health Portrait for six common heritable conditions. Genet Med 2010;12:370-375.
70. Owens KM, Marvin ML, Gelehrter TD, Ruffin MT 4th, Uhlmann WR. Clinical use of the Surgeon General's "My Family Health Portrait" (MFHP) tool: opinions of future health care providers. J Genet Couns 2011;20:510-525.
71. Seltzer MH. Family history (letter). N Engl J Med 2005;352:732.
72. McGuire AL, Majumder MA. Two cheers for GINA? Genome Med 2009;1:6.
73. Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: family history in risk assessment for common diseases. Ann Intern Med 2009;151:878-885.